Cardiovascular safety A thorough QT study found no clinically relevant QTc prolongation, even at supratherapeutic doses
Many practitioners in the optimization space consider anything above 1.0 as something to address
Moreover mitochondrial SHMT appears to be ubiquitous
Sterile water contains no preservatives and is appropriate only for single-use reconstitution
GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas
Dosing begins at 2.5 mg weekly and is gradually increased over several weeks (2.557.51012.515 mg) to minimise gastrointestinal side effects, with maintenance doses ranging from 5 mg to 15 mg depending on individual response and tolerability